Karen Linehan

Director/Board Member at AELIS FARMA

Net worth: 226 356 $ as of 30/05/2026

67 year

76 connections

Health Technology

Consumer Services

Communications

Profile

Karen Linehan is currently an Independent Non-Executive Director at CNH Industrial NV since 2022, a Non-Executive Director at Global Antibiotic Research & Development Partnership, an Independent Director at Aelis Farma SA since 2022, a Member of the Supervisory Board at Sanofi-Aventis Deutschland GmbH, a Member of the Supervisory Board at Hoechst GmbH, and a Member of the Visitors Board at Georgetown University Law Center.
Former roles include Independent Non-Executive Director at VEON Ltd. from 2022 to 2024, Executive VP-Legal Affairs & General Counsel at Sanofi from 2014 to 2021, Associate at Townley & Updike from 1986 to 1990, and Member of the Supervisory Board at EUROAPI SA. Education includes undergraduate and graduate degrees from Georgetown University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CNH INDUSTRIAL NV 0%	25/05/2026	22,170 ( 0% )	226 356 $	30/05/2026

Karen Linehan active positions

Companies	Position	Start
AELIS FARMA	Director/Board Member	31/12/2021
CNH INDUSTRIAL N.V.	Director/Board Member	10/03/2022
Hoechst GmbH Hoechst GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs	Director/Board Member	-
Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services	Director/Board Member	-
Global Antibiotic Research & Development Partnership Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Provides research and development for biological products	Director/Board Member	-
Georgetown University Law Center Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Karen Linehan

Former positions of Karen Linehan

Companies	Position	End
VEON LTD.	Director/Board Member	30/05/2024
SANOFI	General Counsel	30/12/2021
EUROAPI	Director/Board Member	-

See the detail of Karen Linehan's experience

Training of Karen Linehan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Karen Linehan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Georgetown University Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services	Health Technology
VEON Ltd. VEON Ltd. Wireless TelecommunicationsCommunications Provides wireless telecommunications services	Communications
Hoechst GmbH Hoechst GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs	Health Technology
CNH Industrial NV CNH Industrial NV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets agricultural and construction equipment	Producer Manufacturing
Georgetown University Law Center Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aelis Farma SA Aelis Farma SA BiotechnologyHealth Technology Operates as a biotechnology company which develops drugs for brain diseases	Health Technology
Global Antibiotic Research & Development Partnership Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Provides research and development for biological products	Health Technology
EUROAPI SA EUROAPI SA BiotechnologyHealth Technology Develops, manufactures, markets and distributes small molecule APIs	Health Technology